Cargando…

Newfound physiological function of FAIM protein offers hope of novel disease-modifying therapy for Alzheimer’s disease

Detalles Bibliográficos
Autores principales:	Balaj, Allison R., Kaku, Hiroaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358651/ https://www.ncbi.nlm.nih.gov/pubmed/37449619 http://dx.doi.org/10.4103/1673-5374.374003

Ejemplares similares

Small Heat Shock Proteins Collaborate with FAIM to Prevent Accumulation of Misfolded Protein Aggregates
por: Kaku, Hiroaki, et al.
Publicado: (2022)

Why and how does light therapy offer neuroprotection in Parkinson's disease?
por: Mitrofanis, John
Publicado: (2017)

La faim
por: Hamsun, Knut, 1859-1952
Publicado: (1945)

Newfound Hantavirus in Chinese Mole Shrew, Vietnam
por: Song, Jin-Won, et al.
Publicado: (2007)

Lingo-1: a novel target in therapy for Alzheimer's disease?
por: Fernandez-Enright, Francesca, et al.
Publicado: (2016)

FAIM Opposes Aggregation of Mutant SOD1 That Typifies Some Forms of Familial Amyotrophic Lateral Sclerosis
por: Kaku, Hiroaki, et al.
Publicado: (2020)

Biofabrication offers future hope for tackling various obstacles and challenges in tissue engineering and regenerative medicine: A Perspective
por: Mir, Tanveer Ahmad, et al.
Publicado: (2018)

FAIM Is a Non-redundant Defender of Cellular Viability in the Face of Heat and Oxidative Stress and Interferes With Accumulation of Stress-Induced Protein Aggregates
por: Kaku, Hiroaki, et al.
Publicado: (2020)

Advancing combination therapy for Alzheimer's disease
por: Salloway, Stephen P., et al.
Publicado: (2020)

Tetrahydrohyperforin: a neuroprotective modified natural compound against Alzheimer's disease
por: Montecinos-Oliva, Carla, et al.
Publicado: (2015)

Small but mighty: A newfound respect for brief research communications
por: Wen, Jun, et al.
Publicado: (2020)

Walking down the “IL”: The Newfound Marriage between IL-36 and Chronic Obstructive Pulmonary Disease
por: McCombs, Janet E., et al.
Publicado: (2021)

Mens sana in corpore sano: lifestyle changes modify astrocytes to contain Alzheimer’s disease
por: Augusto-Oliveira, Marcus, et al.
Publicado: (2021)

Targeting immunometabolic pathways for combination therapy in Alzheimer's disease
por: Erichsen, Jennifer, et al.
Publicado: (2023)

Finding hope in two pandemics
por: Mgbako, Ofole
Publicado: (2022)

FAIM: An Antagonist of Fas-Killing and Beyond
por: Huo, Jianxin, et al.
Publicado: (2019)

Acetone Sensor Based on FAIMS-MEMS
por: Zhang, Junna, et al.
Publicado: (2021)

Soil Viruses: A New Hope
por: Emerson, Joanne B.
Publicado: (2019)

Molnupiravir: From Hope to Epic Fail?
por: Focosi, Daniele
Publicado: (2022)

Fast vaccine offers hope in battle with Ebola
por: Clarke, Tom
Publicado: (2003)

Fast vaccine offers hope in battle with Ebola
por: Clarke, Tom, et al.
Publicado: (2003)

Preventative medicine and Alzheimer’s disease: is Alzheimer’s disease risk reduction achievable?
por: Sinyor, Benjamin, et al.
Publicado: (2021)

Enrichment of novel Tau isoform with altered biochemical properties in Alzheimer’s disease
por: Ong, Chin-Tong
Publicado: (2023)

Hyperbaric oxygen therapy as a new treatment approach for Alzheimer’s disease
por: Shapira, Ronit, et al.
Publicado: (2018)

The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
por: Walgrave, Hannah, et al.
Publicado: (2021)

Biomarker-guided drug therapy: personalized medicine for treating Alzheimer’s disease
por: Syal, Charvi, et al.
Publicado: (2021)

Direct oral anticoagulants: a new therapy against Alzheimer’s disease?
por: Grossmann, Klaus
Publicado: (2021)

How useful are biomarkers for the diagnosis of Alzheimer’s disease and especially for its therapy?
por: Valenza, Marta, et al.
Publicado: (2022)

Anti-amyloid therapies for Alzheimer disease: finally, good news for patients
por: Ramanan, Vijay K., et al.
Publicado: (2023)

New Hopes for Treatment of Alzheimer’s Disease
por: Akhondzadeh, Shahin
Publicado: ( 201)

Aducanumab—Hope or Disappointment for Alzheimer’s Disease
por: Wojtunik-Kulesza, Karolina, et al.
Publicado: (2023)

Drug design for ever, from hype to hope
por: Seddon, G., et al.
Publicado: (2012)

How mind-body therapies might reduce pathological features of Alzheimer’s disease
por: Hüttenrauch, Melanie, et al.
Publicado: (2022)

Destruction massive - Géopolitique de la faim
por: Ziegler, Jean
Publicado: (2012)

To What Extent is FAIMS Beneficial in the Analysis of Proteins?
por: Cooper, Helen J.
Publicado: (2016)

FAIMS Enhances the Detection of PTM Crosstalk Sites
por: Adoni, Kish R., et al.
Publicado: (2022)

Endocannabinoid metabolism and Alzheimer's disease
por: Chen, Chu
Publicado: (2022)

OxInflammation in Alzheimer’s disease
por: Cervellati, Carlo, et al.
Publicado: (2023)

Is an association of acro-osteolysis, bone fragility, and enchondromatosis a newfound disease caused by an amplification of PTHLH? A case report
por: Echaubard, Stéphane, et al.
Publicado: (2022)

Alpha-synuclein preformed fibrils: a tool to understand Parkinson’s disease and develop disease modifying therapy
por: Chmielarz, Piotr, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5uodl9qab6ueekais7v4jgher7